CD4 and head and neck cancer: Notably, in head and neck cancers, high infiltration of M2 macrophages and resting memory CD4+ T cells is associated with poor clinical outcomes (96), whereas Treg-mediated suppression of effector T cell function can dampen antitumor immunity (97), highlighting the complex and heterogeneous immunobiology across different tumor types.